The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I

2010 ◽  
Vol 69 (9) ◽  
pp. 1589-1595 ◽  
Author(s):  
J. Funovits ◽  
D. Aletaha ◽  
V. Bykerk ◽  
B. Combe ◽  
M. Dougados ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Phase I ◽  
Classification Criteria ◽  
American College Of Rheumatology ◽  
European League Against Rheumatism ◽  
European League

scholarly journals DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis

2019 ◽  
Vol 12 (8) ◽  
pp. e228981 ◽  
Author(s):  
Simonette Padron ◽  
Everett Rogers ◽  
Michelle Demory Beckler ◽  
Marc Kesselman
Keyword(s):  
Rheumatoid Arthritis ◽  
Classification Criteria ◽  
Predisposing Factor ◽  
Dipeptidyl Peptidase 4 ◽  
American College Of Rheumatology ◽  
European League Against Rheumatism ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Inflammatory Arthropathy ◽  
European League

Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitagliptin who developed inflammatory arthritis after taking the drug for 6 months. The patient presented with pain, swelling and erythema in multiple joints and was eventually diagnosed with seronegative rheumatoid arthritis (RA) under the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria. His symptoms continued for several months after stopping sitagliptin and eventually went into remission after a tapered course of steroids, hydroxychloroquine and methotrexate. Furthermore, the patient is HLA-DRB3 positive, a genetic marker that is still being investigated for its role in the pathogenesis of RA and that may have been a predisposing factor in the development of this patient’s inflammatory arthropathy.

Sign in / Sign up

Export Citation Format

Share Document